Brand Intelligence Graphcompany
Company Overview
About Zoetis
Zoetis Inc. is the world's largest animal health company, developing, manufacturing, and commercializing medicines, vaccines, diagnostics, and other technologies for companion animals (dogs, cats, horses) and livestock (cattle, swine, poultry, fish). Spun off from Pfizer in 2013, Zoetis has maintained its position as the global leader in animal health with approximately 300 product lines serving veterinarians, livestock producers, and pet owners in over 100 countries.
Business Model & Competitive Advantage
Zoetis reported approximately $9.1 billion in revenue in FY2024, with companion animals representing roughly 55% of revenue and growing faster than the livestock segment. The shift toward companion animals reflects a powerful cultural and demographic trend: pet ownership is increasing globally, pets are increasingly viewed as family members, and spending per pet is rising as veterinary capabilities advance and pet insurance adoption grows. Zoetis's blockbuster portfolio includes Apoquel and Cytopoint (atopic dermatitis treatments for dogs), Simparica Trio (parasite protection), and Librela/Solensia (monoclonal antibodies for osteoarthritis pain in dogs and cats).
Competitive Landscape 2025–2026
The monoclonal antibody franchise represents Zoetis's most significant innovation: Librela (bedinvetmab) is the first approved monoclonal antibody for pain management in dogs with osteoarthritis, addressing an enormous unmet need in companion animals. These biologics are protected by complex manufacturing processes and intellectual property, creating durable competitive advantages. The livestock segment provides steady cash flows from parasiticides, antibiotics, and vaccines, while the companion animal segment drives premium growth through innovative specialty products.
Recent Activity
View all →Key Differentiators
Market Leader
Zoetis is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $9.1B in revenue, Zoetis operates at enterprise scale with proven market validation.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
GE HealthCare
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designin
Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company — publicly traded on the NASDAQ (NASDAQ: INCY) as an S&P 500 Health Care component — focused on oncology and inflammation,
Biogen
Biogen Inc. is a Cambridge, Massachusetts-based neuroscience biopharmaceutical company — publicly traded on NASDAQ (NASDAQ: BIIB) as an S&P 500 Health Care component — researching, developing, and com
West Pharmaceutical Services
West Pharmaceutical Services, Inc. is the global leader in packaging components and delivery systems for injectable medications, designing and manufacturing the stoppers, closures, caps, and drug deli
Compare Zoetis with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Zoetis? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Zoetis Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Zoetis vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →